GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » EPS (Diluted)

Cangene (FRA:YGE) EPS (Diluted) : €-0.09 (TTM As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene EPS (Diluted)?

Cangene's Earnings per Share (Diluted) for the three months ended in Oct. 2013 was €-0.06. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2013 was €-0.09.

Cangene's EPS (Basic) for the three months ended in Oct. 2013 was €-0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2013 was €-0.09.

Cangene's EPS without NRI for the three months ended in Oct. 2013 was €-0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Oct. 2013 was €-0.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Cangene EPS (Diluted) Historical Data

The historical data trend for Cangene's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene EPS (Diluted) Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.09 0.01 -0.34 0.02

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.04 0.05 -0.04 -0.06

Competitive Comparison of Cangene's EPS (Diluted)

For the Biotechnology subindustry, Cangene's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cangene's PE Ratio falls into.



Cangene EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Cangene's Diluted EPS for the fiscal year that ended in Jul. 2013 is calculated as

Diluted EPS (A: Jul. 2013 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.038-0)/67.342
=0.02

Cangene's Diluted EPS for the quarter that ended in Oct. 2013 is calculated as

Diluted EPS (Q: Oct. 2013 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.822-0)/66.747
=-0.06

EPS (Diluted) for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cangene EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Cangene's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines